Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Clinical trial NCT07698080 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07698080
Sponsor: Hematology department of the 920th hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Lymphoma Thalassemia Aplastic Anemia Myelodysplastic Syndromes

Start date: 2026-07-03
Primary completion: 2028-07-03
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.